Experimental Novartis radiopharma drug shows promise in early study - Reuters

Chronological Source Flow
Back

AI Fusion Summary

Novartis' experimental radiopharmaceutical demonstrated encouraging early results, while a separate study showed a new pill extended survival in patients with advanced pancreatic cancer, offering hope for improved therapies for this deadly disease.
Community Comments
Loading updates...
0